- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Bavarian Nordic
Market Cap: DKK 14.6b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 187.95
7D
2.5%
1Y
17.2%
H. Lundbeck
Market Cap: DKK 36.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 37.40
7D
-0.6%
1Y
-5.6%
Novo Nordisk
Market Cap: DKK 1.0t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 235.30
7D
-5.2%
1Y
-54.9%